Special Issue "State-of-the-Art Molecular and Translational Medicine in Poland"
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 19060
Interests: biochemistry and molecular medicine; pharmacogenomics and nutrigenomics; molecular and cellular mechanisms of disease pathogenesis; personalized patient care; biomarkers of disease: a proteomics approach, assessment of therapy effectiveness; obesity, cancer and inflammation; metabolic disease and adipose tissue biology in patients undergoing bariatric surgery, toxicology, neuroscience, immunology and microbiology
Special Issues, Collections and Topics in MDPI journals
New therapeutic approaches require the knowledge and skills of multiple disciplines. Comprehensive exploration of biological mechanisms and the molecular pathogenesis of major human diseases enable personalized treatment. The integration of omics approaches in combination with modeling approaches and systems biology may play a crucial role in establishing novel clinical applications. Sequencing of individual human genomes has provided the opportunity to develop pharmacogenetics in routine medical practice in order to avoid side effects and to choose the best drug and dose according to each individual genotype.
For this Special Issue, we seek papers focused on mechanisms associated with the development of diseases, including cell-to-cell metabolic crosstalk in physiology and pathology and in cancer research. New insights into molecular mechanisms related to therapy effectiveness and changes in gene expression that have important implications for understanding genotype-phenotype maps are also of importance. There is no doubt that further knowledge is required for the future development of clinically relevant guidelines and new methods for the early detection, prevention, treatment, and prognosis of diseases.
Dr. Małgorzata Wrzosek
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- molecular medicine
- molecular mechanisms
- disease pathogenesis
- genetic variants
- gene expression
- metabolic disorders